FDA to Approve Pfizer’s COVID-19 Vaccine for Emergency Use

A patient receiving Pfizer's COVID-19 vaccine at the University of Maryland School of Medicine in Baltimore, Md., on May 4, 2020. Courtesy of University of Maryland School of Medicine via AP

The Food and Drug Administration (FDA) said Friday that it is working quickly towards finalizing its approval for emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine.

In a joint statement, FDA Commissioner Stephen M. Hahn and Director of the Center for Biologics Evaluation and Research (CBER), Peter Marks, said the agency has notified Pfizer-BioNTech “that it will rapidly work toward finalization and issuance of an emergency use authorization.”